key: cord-1036670-z165qvve
authors: Singh, Jasdeep; Alam, Anwar; Samal, Jasmine; Maeurer, Markus; Ehtesham, Nasreen Z.; Chakaya, Jeremiah; Hira, Subhash; Hasnain, Seyed E.
title: Role of multiple factors likely contributing to severity-mortality of COVID-19
date: 2021-10-05
journal: Infect Genet Evol
DOI: 10.1016/j.meegid.2021.105101
sha: 50a60f54f8ecdd207fa0d7e7767df76d01a732e7
doc_id: 1036670
cord_uid: z165qvve

COVID-19 stalled the world in 2020 and continues to be the greatest health crisis of this generation. While the apparent case fatality rates across fluctuates around ~2% globally, associated mortality/death rate (deaths per million population) varies distinctly across regions from the global average of ~400 per million population. Heterogeneous factors have been linked with COVID-19 associated mortalities and these include age, share of geriatric population, comorbidities, trained immunity and climatic conditions. Apart from direct or indirect role of endemic diseases, dietary factors and host immunity in regulating COVID-19 severity, human behaviour will inevitably control outcome of this pandemic. Comprehensive understanding of these factors will have a bearing on management of future health crises.

As the COVID-19 pandemic swept across the globe starting from Wuhan in November 2019, it disproportionately affected North America and Europe in terms of high rates of hospitalization and mortality, while sparing several countries such as Taiwan and Cambodia that did early shutdown in December 2019 1 . The apparent case fatality rate (CFR which indicates ratio of total deaths to total diagnosed population) from COVID-19 in various WHO (World Health Organization) regions fluctuates around global average of ~2% (Table 1) , recording highest for American and lowest for Western-pacific and Asian regions. For a particular time period, the case fatality rate (signifies severity of the disease) represents number of deaths within the diagnosed population while the mortality rate (signifies incidence of death) represents number of deaths by the total at-risk population. Thus, estimation of the true mortality rate will largely depend on the numerator while the population represents a stable denominator. However, estimation of true case fatality rate can be difficult due to its dependence on both numerator and an unstable denominator, which may lead to its gross under-or overestimation of number of laboratory testing performed. Thus, during an outbreak/pandemic situation, case fatality rates can represent poor indicators of assessing mortality risks. For SARS-CoV outbreak, the actual CFR (10%, calculated at the end) was significantly higher than reported at its beginning (3-5%) 2 . For COVID-19, CFR data in low income settings can greatly overestimate the true estimate of mortality risk due to limited diagnosis. However, population deaths are less likely to be grossly underestimated, thus signifying the mortality rate (number of deaths per million population) as more reliable measure of at-risk population from the disease. For COVID-19, while the CFR was observed to be globally similar, mortality rates presented significant differences across the regions (Table 1 ). The high mortality rate from COVID-19 in American and European regions has been attributed to higher rate of comorbidities (78% deaths had preexisting chronic illness such as diabetes, hypertension and other serious diseases), higher population distribution of elderly aged 65-90 years, and a significant proportion of black people who have high rates of hospitalization and death likely driven by social determinants [3] [4] [5] . This was also in accordance with WHO data showing highest life expectancy by birth in American, Western pacific and European regions (>77 years) compared to South east Asian, African and Eastern-Mediterranean regions (<71 years) for 2019 (WHO Data Life Expectancy). For the African region the lower mortality rate may be related to the low median age of the population (<20 years as per UN estimates for 2020) 6 .

Since the onset of the pandemic, multiple population factors as gender, age, sex, race and non-pharmaceutical measures have been correlated with infection and mortality rate of COVID-19. The current review aims to enhance level of understanding of diverse factors which could be controlling vulnerability of populations towards COVID-19. While we also observe fast spreading of disease owing to emergence of variants of concern/interest 7-9 , knowledge of these factors could help in further management of the pandemic.

Human behavior will be the center for mitigation of current pandemic and will overplay any other factors, which may or may not confer selective advantage against infection. Non pharmaceutical interventions as social distancing, isolation, and increased hygiene practice can effectively reduce the transmission of SARS-CoV-2. For instance in an early survey in UK (March 2020), physical distancing measures resulted in four-fold reduction in reproduction number from Ro~2.6 10 . On the other hand, reduced adherence with social guidelines resulted in higher COVID-19 transmission in Brazil 11 . The second wave in India is another classical example, where non-compliance with appropriate COVID-19 behaviour has resulted in significant healthcare crisis at many levels 12 .

Based on several reports, it was clear that SARS-CoV-2 has a different trend for transmission 13 . Temperature and humidity could play vital role in affecting the prevalence of a disease and transmissibility of pathogens 14 . The climate changes along with socioeconomic and healthcare facilities play a pivotal role in shaping the seasonal patterns of climate sensitive infectious diseases and emergence of new infections in both tropical and non-tropical regions 15 . In a recent report, regions in temperate zone, having mean temperature of 5-11 ºC reported higher COVID-19 cases as compared to tropical African regions 16 , indicating role of temperature in transmission of SARS-CoV-2. Nevertheless, Kumar et al showed a non-linear pattern of transmission of SARS-CoV-2 with temperature, demonstrating lower range of temperatures as favourable factor for the spread of COVID-19 17 .

A bidirectional relationship between COVID-19 and diabetes has been established where either condition can precipitate the other 18 . Recent estimates (age: 20-79 years) on diabetes prevalence were reported to be highest among Western Pacific (11.4%, ~162 million number of people) followed by South-east Asian (11.3%, ~87 million people), North American and Caribbean (11.1%, ~47 million people) and European (6.3%, ~59 million people) regions 19 . Interestingly, the territories with high COVID-19 burden and mortality rate (USA and Brazil) have 2.5-6.9 times less number of diabetic individuals than nations with largest diabetic population: India and China. The apparent inverse relationship between diabetes prevalence and COVID-19 mortality rate in different regions points towards the role of other hidden factors in mediating viral severity in population. The COVID-19 and diabetes nexus is postulated to be centred upon host angiotensin converting enzyme 2 (ACE2) receptor which is expressed in host metabolic organs, such as the pancreas and required by SARS-CoV-2 and related coronaviruses (SARS-CoV-1) to establish viral contact 20 . ACE2 polymorphism has been increasingly linked with COVID-19 susceptibility. A comprehensive genetic analysis from eighty-one thousand human genomes (general population) identified key mutations in ACE2, which are likely to be associated with pulmonary and cardiovascular injury 21 . The African and American populations harboured M383T-D427Y mutations (allele frequencies, 0.003% and 0.01%) and P389H mutation (allele frequency of 0.015%), which cause slightly reduced affinity between spike protein of SARS-CoV-1 and ACE2 22 . In another computational study, single K26R variant of ACE2 with highest frequency in European (0.503%) and American population (0.329%) compared to Asian and American (0.079-0.099%) population was shown to enhance binding with SARS-CoV-2 spike protein 23 . However, a recent survey of genetic variants in ACE2 showed high degree of conservation in viral interacting domains across all populations 24 . The authors stressed on essential role of non-genetic, medical condition and environmental risk factors in governing susceptibility of different populations to SARS-CoV-2. Studies on role of dietary factors in regulating ACE2 expression which further modulate viral severity studies are still in infancy, with current knowledge restricted to animal (mice) studies. Preliminary work in mouse/rat models showed direct role of dietary fat and fructose intake in downregulating ACE2 gene expression 25 26 . Consequently, SARS-CoV-1 challenged ACE2 knocked out mouse/rat models displayed acute respiratory distress syndrome and lung injury while these symptoms improved upon treatment with recombinant ACE2 27 . Alternatively, human recombinant soluble ACE2 was shown to reduce SARS-CoV-2 infection in in-vitro cultures, engineered organoids and in a COVID-19 patient where ACE2 treatment reduced bilateral multifocal consolidations 28 29 . A recent community-based, cohort study of 6.9 million COVID-19 patients in UK concluded linear correlation between BMI (Body Mass Index) and intensive-care unit admissions 30 . The study concluded that risk of severe COVID-19 and deaths increases at BMI>23kg/m 2 . Mapping of nations with highest (>0.1 million) cumulative COVID-19 related deaths 31 32 onto their daily caloric supply per person and percentage of obese persons 33 places nations with highest mortality rate in an entirely distinct quadrant (Figure 1 ). This quadrant pertains to >20% obese population (BMI>25) with >3000 kcal daily caloric supply per person. Further inclusion of other tropical regions of Africa, South east Asia, Western pacific (which have recorded a low mortality rate) clustered along India to a separate quadrant with < 15% of obese/overweight individuals and <3000 kcal daily caloric supply per person. The observations were consistent with study by Micha R. et al on higher consumption of saturated and trans fats in North American and European regions compared to tropical nations 34 . Alternatively, consumption of fructose in the form of high fructose corn syrups was also reported to be higher in North American and European nations compared to the rest of the world 35 . It may be thus postulated that high dietary consumption of fats or fructose can affect ACE2 expression in humans and might explain variable COVID-19 associated mortalities across regions worldwide. Besides its role in regulating ACE2 expression, obesity/high BMI also impairs immune function, reduced lung function and difficult ventilation, which can increase risk of severe COVID-19 illness.

A growing body of evidence suggests that heterologous cell-mediated innate immunity (termed as "trained immunity") imparts beneficial non-specific protective effects against J o u r n a l P r e -p r o o f Journal Pre-proof COVID-19 disease severity 36 . Many microbial stimuli including bacteria, viruses, fungal cells, and their components (LPS, β-glucan, chitin) are efficient inducers of memory response associated with trained immunity. Interestingly, many epidemiological studies in the past have shown that tropical regions have been more adversely affected by infectious diseases than temperate regions 37 . Prior exposure with pathogens raises chances of inducing innate memory responses. SARS-CoV-2 has brought the concept of importance of innate immunity to the forefront and the role of trained immunity in conferring protections against unrelated infections 38 , or through "ACTIVATE" clinical trials for inducing trained memory responses in aged or high risk individuals 39 . CD8 T cells recognize multiple regions of N proteins and induce multi-specific and long-lasting immune responses. The memory T cells display crossreactivity to SARS-CoV-2 for more than 15 years. CD4 T cells recognize spike protein and regulate the generation of memory B cells that target SARS-CoV-2 spike proteins 40 . Memory B cells are long-lasting as compared to the antibodies and can provide durability in the immune response against SARS-CoV-2. Host directed therapies such as the use of umbilical cord-derived mesenchymal stem cells and anti-IL6 receptor antibodies have shown promising results on COVID-19 patients 41 . Apart from the anti-viral approaches for specific treatment of COVID-19, scientists are also exploring broader interventions to support a healthy immune response through nutritional interventions that may regulate microbiota-mediated immunomodulatory effects. Hence, the role of immunonutrients to boost the immune system as part of the strategies to minimize the complications of SARS-CoV-2 infection is gaining global recognition 42 . Some of the studies have shown that specific nutrients such as omega-3 fatty acid, vitamin C, Vitamin D, Zinc and selenium may help in improving the functioning of immune system, especially among aged people 43 48 . A probable role of pneumococcal vaccine in protecting against severity of COVID-19 disease in an observational cohort study at Mayo clinic has been proposed 49 . BCG, discovered nearly a century ago, has proven its efficacy in providing protection against wide repertoire of unrelated pathogens including viruses, especially those causing respiratory infections in children [50] [51] [52] . Vaccinating individuals with BCG for boosting the trained immunity to protect against COVID-19 has gained global attention 53 . Countries, including India, where BCG is part of universal vaccination programme has shown relatively lesser severe impact of COVID-19 pandemic 54 , prior to the second wave, the severity of which had more to do with human behaviour. Cause-specific death rate/100,000 population was significantly lower in countries having BCG immunization policy (mostly in tropical regions 55 ), compared to those where a universal BCG vaccination policy did not exist 54 . Another recent observational study indicated that exposure to Mycobacterium spp (including BCG) is negatively correlated with COVID-19 disease and mortality in European countries 36 . Though the heterologous immunity conferred by BCG against SARS-CoV-2 infection is still debatable and uncertain, an interesting study recently revealed that BCG protects elderly against respiratory infections (interim results) (48) , implying a role of BCG vaccination, though speculative, in circumventing COVID-19 spread. However, the beneficial effects of BCG vaccination against COVID-19 were not observed in Brazil. One of the contributing factors in this disparity could be lower median age of population in India (28.2 years) compared to Brazil (33.5 years) (population.un.org/). Another factor could be a single SARS-CoV-2 variant in Brazil since the beginning of the pandemic ( Figure S1 ) while for India, its temporal analysis showed co-dominance of multiple viral variants. While recognising the potential beneficial effects of BCG vaccination we agree with others who have urged that robust clinical trial evidence is needed before BCG vaccination can be recommended as an intervention to be applied on a wide scale for the prevention of COVID-19 morbidity and mortality 56 . In fact, scientists are proposing the concept of "heterologous vaccine boosting" which means a non-specific vaccine as a boost, second dose after the COVID-19 specific vaccine prime dose, especially when the second dose of COVID-19 vaccine is unavailable 57 58 . This is right now only a hypothesis which warrants further investigations and trials.

Though we have focused on several clinical and epidemiological studies for our interpretation and analysis, still there are limitations to this review. The factors linked to COVID-19 severity should be interpreted with caution as there are likely many confounding factors that have not been accounted for. For example, COVID-19 testing and hospitalization vary from place to place and time to time, that may impact the outcome of SARS-CoV-2 infection. Role of trained immunity in fighting against COVID-19 needs additional studies addressing the "cause-effect" phenomenon. We need data from various ongoing clinical trials (addressing effect of BCG on COVID-19 severity) to strengthen the correlation. A certain bias can also occur depending on the timing of our search and analysis as spatial and temporal variations impacted the spread of COVID-19 peaks. Dietary intake and lifestyle show variations from J o u r n a l P r e -p r o o f Journal Pre-proof region to region, and even within a particular region/country, largely governed by socioeconomic factors. The emergence of different variants of SARS-CoV-2 with higher binding affinity towards hACE2 along with immune escape ability 7 8 has been attributed to the increased COVID-19 positivity rate. These confounding variables need to be adjusted before assessing the actual mortality/morbidity rate of a given population.

The gradual spread of COVID-19 continues to impact and disrupt healthcare settings and the global economy in an unprecedented way. Genetic variations in SARS-CoV-2 have compounded its increased transmission and infectivity, as evident from global sweep of D614G variant in 2020 and N501Y variants in 2021 59 . However, multiple non-biological factors such as environment, socio-behavioural aspects, comorbidity etc. appear to contribute towards disparate COVID-19 associated mortality rate globally 60 . Additionally, endemic microbial infections, dietary factors and trained immunity substantially impacts COVID-19 disease burden. Given the rapid emergence of contagious mutants and an urgency to vaccinate all, non-specific vaccines have been proposed to be used to boost immunological response to COVID-19 specific vaccine 57 58 . Taking clues from these non-genetic factors and past lessons from the HIV pandemic, SARS-CoV-1, MERS-CoV (Middle East Respiratory Syndrome) epidemics and other disease outbreaks, it is imperative to fully understand and utilize host-directed responses against infectious diseases. Comprehensive understanding of host-directed responses and population differences can be helpful in managing the current and future pandemics. J o u r n a l P r e -p r o o f Summary • COVID-19 is an exceptional reminder to the world that besides robust healthcare systems, we still need to understand plethora of factors which can predispose the population to the pathogenic diseases.

• Analysis on correlation of these multiple non-biological factors as dietary, immunological, environmental and endemic diseases apart from human behavior can broaden our understanding on COVID-19 severity and mortality globally.

• These factors also highlight that besides developing direct interventional strategies through antiviral drugs/neutralizing antibodies, it is also imperative to fully understand and utilize host-directed responses against microbial infections.

• While COVID-19 has reshaped our healthcare responses like never before, understanding global population differences in the context of miscellaneous cofactors will aid in the management of future health crises J o u r n a l P r e -p r o o f

COVID-19 and African Americans

Natural History of Asymptomatic SARS-CoV-2 Infection

Factors associated with COVID-19-related death using OpenSAFELY

The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study

SARS-CoV-2 variants of concern are emerging in India

Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications

Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity

Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK

COVID-19 outbreak in Brazil: adherence to national preventive measures and impact on people's lives, an online survey

India's COVID-19 emergency

Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19)

Effects of temperature and humidity on the spread of COVID-19: A systematic review

Climate change influences infectious diseases both in the Arctic and the tropics: joining the dots

COVID-19 pandemic: The African paradox

Exploring dependence of COVID-19 on environmental factors and spread prediction in India

The Lancet Diabetes E. COVID-19 and diabetes

Global and regional diabetes prevalence estimates for

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein

A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Fructose-rich diet induces gender-specific changes in expression of the renin-angiotensin system in rat heart and upregulates the ACE/AT1R axis in the male rat aorta

ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Human recombinant soluble ACE2 in severe COVID-19. The Lancet Respiratory medicine 2020

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Associations between body-mass index and COVID-19 severity in 6&#xb7

Coronavirus Pandemic (COVID-19)

An interactive web-based dashboard to track COVID-19 in real time

Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys

Countries that use large amounts of high fructose corn syrup have higher rates of type 2 diabetes

Trained immunity" from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes

Tropical environments, human activities, and the transmission of infectious diseases

COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development

Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly

Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help

Host-directed therapies for COVID-19

Immunometabolism: new insights and lessons from antigendirected cellular immune responses

COVID-19: is there a role for immunonutrition, particularly in the over 65s? BMJ Nutrition, Prevention &amp

Could Immunonutrition Help in the Fight against COVID-19 in Cancer Patient?

Should immunonutrition become routine in critically ill patients? A systematic review of the evidence

Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients

Relationship between MMR vaccination and severity of Covid-19 infection. Survey among primary care physicians

Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil

Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death

Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?

Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study

Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial

BCG-induced trained immunity: can it offer protection against COVID-19?

Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?

Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

Bacille Calmette-Guerin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection -Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base

Can existing unrelated vaccines boost a COVID-19 vaccine prime?

Heterologous vaccine interventions: boosting immunity against future pandemics

Lethal zoonotic coronavirus infections of humans -comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome

Two parallel pandemics: the challenges faced by countries with COVID-19 and TB. The international journal of tuberculosis and lung disease : the official journal of the International Union against

Burden of Disease

CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants. The Lancet Infectious diseases

SEH is a JC Bose National Fellow, Department of Science and Technology (DST), GoI and Robert Koch Fellow, Robert Koch Institute, Berlin, Germany. JSi is a recipient of DHR Young Scientist fellowship. JSa is a recipient of ICMR post-doctoral fellowship

 Table 1 . COVID-19 burden across various regions (as of September 1 2021).Reported mortality and case fatality rate was sourced from WHO Coronavirus (COVID-19) Dashboard (covid19.who.int/). Case fatality rate is defined as percent ratio of total deaths to total diagnosed population. Mortality rate is defined as percent ratio of total deaths to total atrisk population.